Prior to 2020, face to face (F2F) detailing was the central pillar of pharma communication with HCPs and, while recent years had seen some movement towards a more orchestrated multichannel approach, remained the main channel for raising awareness and driving uptake of new products. The restrictions on F2F contacts imposed by the COVID-19 pandemic triggered an explosion in the volume of live e-detailing and telephone detailing, as the only alternatives to maintaining interactive contact between reps and physicians.
Channel Impact: can virtual contacts really pick up the slack? – IQVIA
